Do you have the same question? Follow this Question
Apr 15, 2026 - 02:52 PM
We’ve provided several answers to questions related to Eysuvis (Loteprednol Etabonate Ophthalmic Suspension) , see some other helpful Q&A related to this product.
Question: What are the main conditions treated by this medication?
Answer: This medication is used to treat the signs and symptoms of dry eye disease, such as irritation, redness, and inflammation. Treating dry eye disease can improve comfort, vision quality, and overall eye health.
Question: Is this medication approved by the US FDA?
Answer: Yes, this medication is licensed by the US FDA (United States Food and Drug Administration), which means it has undergone rigorous testing for safety and efficacy. FDA approval provides assurance of quality and regulatory oversight.
Question: What is the chemical formula for the active ingredient?
Answer: The chemical formula for loteprednol etabonate is C24H31ClO7. Knowing the chemical formula is important for pharmacists and healthcare professionals to verify the medication's composition and ensure safety for patients.
Question: What is the strength of the active ingredient in this eye drop?
Answer: The strength of the active ingredient in this eye drop is 0.25% loteprednol etabonate, meaning each milliliter contains 2.5 mg of the medication. This precise dosing helps ensure consistent and effective treatment for dry eye disease symptoms.
View all Eysuvis (Loteprednol Etabonate Ophthalmic Suspension) Questions & Answers
